#SERVICE DETAILS
Pharmacoeconomic Studies
Turning data into healthcare decisions
ES-CR translates clinical and economic data into evidence supporting market access and planning activities for pharmaceutical and biotechnology companies.
We integrate clinical evidence, cost structures, health outcomes and real-world parameters to develop health economic models supporting analysis and decision processes.
Our work contributes to resource allocation assessment, budget impact evaluation and market access activities through transparent and structured results.
Strategic support for economic evaluation
Value Dossiers
We prepare structured value dossiers that synthesize clinical evidence, economics, and strategic arguments to support market access and decision-making.
Descriptive Cost Studies
We conduct descriptive analyses, including cost-of-illness studies, to quantify the economic burden associated with diseases and healthcare interventions.
Cost-Effectiveness Modeling
We develop cost-effectiveness models integrating clinical outcomes, resource utilization, and cost data to support health technology assessment and reimbursement decision-making.
Budget Impact Analysis
We evaluate short- and long-term budget consequences linked to treatment adoption, offering clear forecasts to guide resource allocation strategies.
Local Adaptation of Global Models
We adapt international economic models to local contexts by adjusting epidemiology, cost inputs, and market parameters for accurate regional relevance.
Scientific and operational expertise for
pharma and healthcare stakeholders.
"Every clinical study is a step forward for those waiting to heal."
Team ES-CR